chloramphenicol has been researched along with Respiratory Distress Syndrome, Newborn in 2 studies
Amphenicol: Chloramphenicol and its derivatives.
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lorber, J | 1 |
| Braudo, M | 1 |
| Keith, JD | 1 |
1 trial available for chloramphenicol and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
The value of digitalis in the respiratory distress syndrome: a controlled study.
Topics: Birth Weight; Body Temperature; Chloramphenicol; Clinical Trials as Topic; Digitalis Glycosides; Ele | 1969 |
1 other study available for chloramphenicol and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Neonatal E. coli meningitis, hydrocephalus, respiratory distress syndrome, full recovery after temporary blindness.
Topics: Blindness; Child, Preschool; Chloramphenicol; Escherichia coli Infections; Humans; Hydrocephalus; Hy | 1973 |